Global Lancets Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Lancets market size was valued at US$ 1424.5 million in 2023. With growing demand in downstream market, the Lancets is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Lancets market. Lancets are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lancets. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lancets market.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
Key Features:
The report on Lancets market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lancets market. It may include historical data, market segmentation by Type (e.g., Safety Lancets, Ordinary Lancets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lancets market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lancets market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lancets industry. This include advancements in Lancets technology, Lancets new entrants, Lancets new investment, and other innovations that are shaping the future of Lancets.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lancets market. It includes factors influencing customer ' purchasing decisions, preferences for Lancets product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lancets market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lancets market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lancets market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lancets industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lancets market.
Market Segmentation:
Lancets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Lancets market?
What factors are driving Lancets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lancets market opportunities vary by end market size?
How does Lancets break out type, application?
According to our LPI (LP Information) latest study, the global Lancets market size was valued at US$ 1424.5 million in 2023. With growing demand in downstream market, the Lancets is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Lancets market. Lancets are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lancets. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lancets market.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
Key Features:
The report on Lancets market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lancets market. It may include historical data, market segmentation by Type (e.g., Safety Lancets, Ordinary Lancets), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lancets market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lancets market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lancets industry. This include advancements in Lancets technology, Lancets new entrants, Lancets new investment, and other innovations that are shaping the future of Lancets.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lancets market. It includes factors influencing customer ' purchasing decisions, preferences for Lancets product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lancets market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lancets market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lancets market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lancets industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lancets market.
Market Segmentation:
Lancets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Safety Lancets
- Ordinary Lancets
- Cholesterol Tests
- Glucose Tests
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Lifescan
- BD
- Ascensia
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- AgaMatrix
- Smiths Medical
- Sarstedt
- Sinocare
- Yicheng
- Yuwell
- Greiner Bio One
What is the 10-year outlook for the global Lancets market?
What factors are driving Lancets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lancets market opportunities vary by end market size?
How does Lancets break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lancets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lancets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lancets by Country/Region, 2019, 2023 & 2030
2.2 Lancets Segment by Type
2.2.1 Safety Lancets
2.2.2 Ordinary Lancets
2.3 Lancets Sales by Type
2.3.1 Global Lancets Sales Market Share by Type (2019-2024)
2.3.2 Global Lancets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lancets Sale Price by Type (2019-2024)
2.4 Lancets Segment by Application
2.4.1 Cholesterol Tests
2.4.2 Glucose Tests
2.4.3 Others
2.5 Lancets Sales by Application
2.5.1 Global Lancets Sale Market Share by Application (2019-2024)
2.5.2 Global Lancets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lancets Sale Price by Application (2019-2024)
3 GLOBAL LANCETS BY COMPANY
3.1 Global Lancets Breakdown Data by Company
3.1.1 Global Lancets Annual Sales by Company (2019-2024)
3.1.2 Global Lancets Sales Market Share by Company (2019-2024)
3.2 Global Lancets Annual Revenue by Company (2019-2024)
3.2.1 Global Lancets Revenue by Company (2019-2024)
3.2.2 Global Lancets Revenue Market Share by Company (2019-2024)
3.3 Global Lancets Sale Price by Company
3.4 Key Manufacturers Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lancets Product Location Distribution
3.4.2 Players Lancets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LANCETS BY GEOGRAPHIC REGION
4.1 World Historic Lancets Market Size by Geographic Region (2019-2024)
4.1.1 Global Lancets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lancets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lancets Market Size by Country/Region (2019-2024)
4.2.1 Global Lancets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lancets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lancets Sales Growth
4.4 APAC Lancets Sales Growth
4.5 Europe Lancets Sales Growth
4.6 Middle East & Africa Lancets Sales Growth
5 AMERICAS
5.1 Americas Lancets Sales by Country
5.1.1 Americas Lancets Sales by Country (2019-2024)
5.1.2 Americas Lancets Revenue by Country (2019-2024)
5.2 Americas Lancets Sales by Type
5.3 Americas Lancets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lancets Sales by Region
6.1.1 APAC Lancets Sales by Region (2019-2024)
6.1.2 APAC Lancets Revenue by Region (2019-2024)
6.2 APAC Lancets Sales by Type
6.3 APAC Lancets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lancets by Country
7.1.1 Europe Lancets Sales by Country (2019-2024)
7.1.2 Europe Lancets Revenue by Country (2019-2024)
7.2 Europe Lancets Sales by Type
7.3 Europe Lancets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lancets by Country
8.1.1 Middle East & Africa Lancets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lancets Revenue by Country (2019-2024)
8.2 Middle East & Africa Lancets Sales by Type
8.3 Middle East & Africa Lancets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lancets
10.3 Manufacturing Process Analysis of Lancets
10.4 Industry Chain Structure of Lancets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lancets Distributors
11.3 Lancets Customer
12 WORLD FORECAST REVIEW FOR LANCETS BY GEOGRAPHIC REGION
12.1 Global Lancets Market Size Forecast by Region
12.1.1 Global Lancets Forecast by Region (2025-2030)
12.1.2 Global Lancets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lancets Forecast by Type
12.7 Global Lancets Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Lancets Product Portfolios and Specifications
13.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Lancets Product Portfolios and Specifications
13.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Lancets Product Portfolios and Specifications
13.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Ascensia
13.4.1 Ascensia Company Information
13.4.2 Ascensia Lancets Product Portfolios and Specifications
13.4.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ascensia Main Business Overview
13.4.5 Ascensia Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Lancets Product Portfolios and Specifications
13.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 B. Braun
13.6.1 B. Braun Company Information
13.6.2 B. Braun Lancets Product Portfolios and Specifications
13.6.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 B. Braun Main Business Overview
13.6.5 B. Braun Latest Developments
13.7 ARKRAY
13.7.1 ARKRAY Company Information
13.7.2 ARKRAY Lancets Product Portfolios and Specifications
13.7.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ARKRAY Main Business Overview
13.7.5 ARKRAY Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Lancets Product Portfolios and Specifications
13.8.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 I-SENS
13.9.1 I-SENS Company Information
13.9.2 I-SENS Lancets Product Portfolios and Specifications
13.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 I-SENS Main Business Overview
13.9.5 I-SENS Latest Developments
13.10 Nipro
13.10.1 Nipro Company Information
13.10.2 Nipro Lancets Product Portfolios and Specifications
13.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nipro Main Business Overview
13.10.5 Nipro Latest Developments
13.11 Omron
13.11.1 Omron Company Information
13.11.2 Omron Lancets Product Portfolios and Specifications
13.11.3 Omron Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Omron Main Business Overview
13.11.5 Omron Latest Developments
13.12 AgaMatrix
13.12.1 AgaMatrix Company Information
13.12.2 AgaMatrix Lancets Product Portfolios and Specifications
13.12.3 AgaMatrix Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 AgaMatrix Main Business Overview
13.12.5 AgaMatrix Latest Developments
13.13 Smiths Medical
13.13.1 Smiths Medical Company Information
13.13.2 Smiths Medical Lancets Product Portfolios and Specifications
13.13.3 Smiths Medical Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Smiths Medical Main Business Overview
13.13.5 Smiths Medical Latest Developments
13.14 Sarstedt
13.14.1 Sarstedt Company Information
13.14.2 Sarstedt Lancets Product Portfolios and Specifications
13.14.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sarstedt Main Business Overview
13.14.5 Sarstedt Latest Developments
13.15 Sinocare
13.15.1 Sinocare Company Information
13.15.2 Sinocare Lancets Product Portfolios and Specifications
13.15.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Sinocare Main Business Overview
13.15.5 Sinocare Latest Developments
13.16 Yicheng
13.16.1 Yicheng Company Information
13.16.2 Yicheng Lancets Product Portfolios and Specifications
13.16.3 Yicheng Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Yicheng Main Business Overview
13.16.5 Yicheng Latest Developments
13.17 Yuwell
13.17.1 Yuwell Company Information
13.17.2 Yuwell Lancets Product Portfolios and Specifications
13.17.3 Yuwell Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Yuwell Main Business Overview
13.17.5 Yuwell Latest Developments
13.18 Greiner Bio One
13.18.1 Greiner Bio One Company Information
13.18.2 Greiner Bio One Lancets Product Portfolios and Specifications
13.18.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Greiner Bio One Main Business Overview
13.18.5 Greiner Bio One Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lancets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lancets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lancets by Country/Region, 2019, 2023 & 2030
2.2 Lancets Segment by Type
2.2.1 Safety Lancets
2.2.2 Ordinary Lancets
2.3 Lancets Sales by Type
2.3.1 Global Lancets Sales Market Share by Type (2019-2024)
2.3.2 Global Lancets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lancets Sale Price by Type (2019-2024)
2.4 Lancets Segment by Application
2.4.1 Cholesterol Tests
2.4.2 Glucose Tests
2.4.3 Others
2.5 Lancets Sales by Application
2.5.1 Global Lancets Sale Market Share by Application (2019-2024)
2.5.2 Global Lancets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lancets Sale Price by Application (2019-2024)
3 GLOBAL LANCETS BY COMPANY
3.1 Global Lancets Breakdown Data by Company
3.1.1 Global Lancets Annual Sales by Company (2019-2024)
3.1.2 Global Lancets Sales Market Share by Company (2019-2024)
3.2 Global Lancets Annual Revenue by Company (2019-2024)
3.2.1 Global Lancets Revenue by Company (2019-2024)
3.2.2 Global Lancets Revenue Market Share by Company (2019-2024)
3.3 Global Lancets Sale Price by Company
3.4 Key Manufacturers Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lancets Product Location Distribution
3.4.2 Players Lancets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LANCETS BY GEOGRAPHIC REGION
4.1 World Historic Lancets Market Size by Geographic Region (2019-2024)
4.1.1 Global Lancets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lancets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lancets Market Size by Country/Region (2019-2024)
4.2.1 Global Lancets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lancets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lancets Sales Growth
4.4 APAC Lancets Sales Growth
4.5 Europe Lancets Sales Growth
4.6 Middle East & Africa Lancets Sales Growth
5 AMERICAS
5.1 Americas Lancets Sales by Country
5.1.1 Americas Lancets Sales by Country (2019-2024)
5.1.2 Americas Lancets Revenue by Country (2019-2024)
5.2 Americas Lancets Sales by Type
5.3 Americas Lancets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lancets Sales by Region
6.1.1 APAC Lancets Sales by Region (2019-2024)
6.1.2 APAC Lancets Revenue by Region (2019-2024)
6.2 APAC Lancets Sales by Type
6.3 APAC Lancets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lancets by Country
7.1.1 Europe Lancets Sales by Country (2019-2024)
7.1.2 Europe Lancets Revenue by Country (2019-2024)
7.2 Europe Lancets Sales by Type
7.3 Europe Lancets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lancets by Country
8.1.1 Middle East & Africa Lancets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lancets Revenue by Country (2019-2024)
8.2 Middle East & Africa Lancets Sales by Type
8.3 Middle East & Africa Lancets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lancets
10.3 Manufacturing Process Analysis of Lancets
10.4 Industry Chain Structure of Lancets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lancets Distributors
11.3 Lancets Customer
12 WORLD FORECAST REVIEW FOR LANCETS BY GEOGRAPHIC REGION
12.1 Global Lancets Market Size Forecast by Region
12.1.1 Global Lancets Forecast by Region (2025-2030)
12.1.2 Global Lancets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lancets Forecast by Type
12.7 Global Lancets Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Lancets Product Portfolios and Specifications
13.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Lancets Product Portfolios and Specifications
13.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Lancets Product Portfolios and Specifications
13.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Ascensia
13.4.1 Ascensia Company Information
13.4.2 Ascensia Lancets Product Portfolios and Specifications
13.4.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ascensia Main Business Overview
13.4.5 Ascensia Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Lancets Product Portfolios and Specifications
13.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 B. Braun
13.6.1 B. Braun Company Information
13.6.2 B. Braun Lancets Product Portfolios and Specifications
13.6.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 B. Braun Main Business Overview
13.6.5 B. Braun Latest Developments
13.7 ARKRAY
13.7.1 ARKRAY Company Information
13.7.2 ARKRAY Lancets Product Portfolios and Specifications
13.7.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ARKRAY Main Business Overview
13.7.5 ARKRAY Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Lancets Product Portfolios and Specifications
13.8.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 I-SENS
13.9.1 I-SENS Company Information
13.9.2 I-SENS Lancets Product Portfolios and Specifications
13.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 I-SENS Main Business Overview
13.9.5 I-SENS Latest Developments
13.10 Nipro
13.10.1 Nipro Company Information
13.10.2 Nipro Lancets Product Portfolios and Specifications
13.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nipro Main Business Overview
13.10.5 Nipro Latest Developments
13.11 Omron
13.11.1 Omron Company Information
13.11.2 Omron Lancets Product Portfolios and Specifications
13.11.3 Omron Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Omron Main Business Overview
13.11.5 Omron Latest Developments
13.12 AgaMatrix
13.12.1 AgaMatrix Company Information
13.12.2 AgaMatrix Lancets Product Portfolios and Specifications
13.12.3 AgaMatrix Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 AgaMatrix Main Business Overview
13.12.5 AgaMatrix Latest Developments
13.13 Smiths Medical
13.13.1 Smiths Medical Company Information
13.13.2 Smiths Medical Lancets Product Portfolios and Specifications
13.13.3 Smiths Medical Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Smiths Medical Main Business Overview
13.13.5 Smiths Medical Latest Developments
13.14 Sarstedt
13.14.1 Sarstedt Company Information
13.14.2 Sarstedt Lancets Product Portfolios and Specifications
13.14.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sarstedt Main Business Overview
13.14.5 Sarstedt Latest Developments
13.15 Sinocare
13.15.1 Sinocare Company Information
13.15.2 Sinocare Lancets Product Portfolios and Specifications
13.15.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Sinocare Main Business Overview
13.15.5 Sinocare Latest Developments
13.16 Yicheng
13.16.1 Yicheng Company Information
13.16.2 Yicheng Lancets Product Portfolios and Specifications
13.16.3 Yicheng Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Yicheng Main Business Overview
13.16.5 Yicheng Latest Developments
13.17 Yuwell
13.17.1 Yuwell Company Information
13.17.2 Yuwell Lancets Product Portfolios and Specifications
13.17.3 Yuwell Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Yuwell Main Business Overview
13.17.5 Yuwell Latest Developments
13.18 Greiner Bio One
13.18.1 Greiner Bio One Company Information
13.18.2 Greiner Bio One Lancets Product Portfolios and Specifications
13.18.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Greiner Bio One Main Business Overview
13.18.5 Greiner Bio One Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lancets Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Lancets Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Safety Lancets
Table 4. Major Players of Ordinary Lancets
Table 5. Global Lancets Sales by Type (2019-2024) & (K Units)
Table 6. Global Lancets Sales Market Share by Type (2019-2024)
Table 7. Global Lancets Revenue by Type (2019-2024) & ($ million)
Table 8. Global Lancets Revenue Market Share by Type (2019-2024)
Table 9. Global Lancets Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Lancets Sales by Application (2019-2024) & (K Units)
Table 11. Global Lancets Sales Market Share by Application (2019-2024)
Table 12. Global Lancets Revenue by Application (2019-2024)
Table 13. Global Lancets Revenue Market Share by Application (2019-2024)
Table 14. Global Lancets Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Lancets Sales by Company (2019-2024) & (K Units)
Table 16. Global Lancets Sales Market Share by Company (2019-2024)
Table 17. Global Lancets Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Lancets Revenue Market Share by Company (2019-2024)
Table 19. Global Lancets Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Lancets Producing Area Distribution and Sales Area
Table 21. Players Lancets Products Offered
Table 22. Lancets Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lancets Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Lancets Sales Market Share Geographic Region (2019-2024)
Table 27. Global Lancets Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Lancets Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Lancets Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Lancets Sales Market Share by Country/Region (2019-2024)
Table 31. Global Lancets Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Lancets Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Lancets Sales by Country (2019-2024) & (K Units)
Table 34. Americas Lancets Sales Market Share by Country (2019-2024)
Table 35. Americas Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Lancets Revenue Market Share by Country (2019-2024)
Table 37. Americas Lancets Sales by Type (2019-2024) & (K Units)
Table 38. Americas Lancets Sales by Application (2019-2024) & (K Units)
Table 39. APAC Lancets Sales by Region (2019-2024) & (K Units)
Table 40. APAC Lancets Sales Market Share by Region (2019-2024)
Table 41. APAC Lancets Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Lancets Revenue Market Share by Region (2019-2024)
Table 43. APAC Lancets Sales by Type (2019-2024) & (K Units)
Table 44. APAC Lancets Sales by Application (2019-2024) & (K Units)
Table 45. Europe Lancets Sales by Country (2019-2024) & (K Units)
Table 46. Europe Lancets Sales Market Share by Country (2019-2024)
Table 47. Europe Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Lancets Revenue Market Share by Country (2019-2024)
Table 49. Europe Lancets Sales by Type (2019-2024) & (K Units)
Table 50. Europe Lancets Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Lancets Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Lancets Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Lancets Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Lancets Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Lancets Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Lancets
Table 58. Key Market Challenges & Risks of Lancets
Table 59. Key Industry Trends of Lancets
Table 60. Lancets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lancets Distributors List
Table 63. Lancets Customer List
Table 64. Global Lancets Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Lancets Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Lancets Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Lancets Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Lancets Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Lancets Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Lancets Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Lancets Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Roche Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Lancets Product Portfolios and Specifications
Table 80. Roche Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Lifescan Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 84. Lifescan Lancets Product Portfolios and Specifications
Table 85. Lifescan Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Lifescan Main Business
Table 87. Lifescan Latest Developments
Table 88. BD Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Lancets Product Portfolios and Specifications
Table 90. BD Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Ascensia Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 94. Ascensia Lancets Product Portfolios and Specifications
Table 95. Ascensia Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Ascensia Main Business
Table 97. Ascensia Latest Developments
Table 98. Abbott Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Lancets Product Portfolios and Specifications
Table 100. Abbott Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. B. Braun Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 104. B. Braun Lancets Product Portfolios and Specifications
Table 105. B. Braun Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. B. Braun Main Business
Table 107. B. Braun Latest Developments
Table 108. ARKRAY Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 109. ARKRAY Lancets Product Portfolios and Specifications
Table 110. ARKRAY Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. ARKRAY Main Business
Table 112. ARKRAY Latest Developments
Table 113. Terumo Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 114. Terumo Lancets Product Portfolios and Specifications
Table 115. Terumo Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Terumo Main Business
Table 117. Terumo Latest Developments
Table 118. I-SENS Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 119. I-SENS Lancets Product Portfolios and Specifications
Table 120. I-SENS Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. I-SENS Main Business
Table 122. I-SENS Latest Developments
Table 123. Nipro Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Lancets Product Portfolios and Specifications
Table 125. Nipro Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Nipro Main Business
Table 127. Nipro Latest Developments
Table 128. Omron Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 129. Omron Lancets Product Portfolios and Specifications
Table 130. Omron Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Omron Main Business
Table 132. Omron Latest Developments
Table 133. AgaMatrix Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 134. AgaMatrix Lancets Product Portfolios and Specifications
Table 135. AgaMatrix Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. AgaMatrix Main Business
Table 137. AgaMatrix Latest Developments
Table 138. Smiths Medical Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 139. Smiths Medical Lancets Product Portfolios and Specifications
Table 140. Smiths Medical Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Smiths Medical Main Business
Table 142. Smiths Medical Latest Developments
Table 143. Sarstedt Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 144. Sarstedt Lancets Product Portfolios and Specifications
Table 145. Sarstedt Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Sarstedt Main Business
Table 147. Sarstedt Latest Developments
Table 148. Sinocare Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 149. Sinocare Lancets Product Portfolios and Specifications
Table 150. Sinocare Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Sinocare Main Business
Table 152. Sinocare Latest Developments
Table 153. Yicheng Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 154. Yicheng Lancets Product Portfolios and Specifications
Table 155. Yicheng Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Yicheng Main Business
Table 157. Yicheng Latest Developments
Table 158. Yuwell Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuwell Lancets Product Portfolios and Specifications
Table 160. Yuwell Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. Yuwell Main Business
Table 162. Yuwell Latest Developments
Table 163. Greiner Bio One Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 164. Greiner Bio One Lancets Product Portfolios and Specifications
Table 165. Greiner Bio One Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 166. Greiner Bio One Main Business
Table 167. Greiner Bio One Latest Developments
Table 1. Lancets Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Lancets Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Safety Lancets
Table 4. Major Players of Ordinary Lancets
Table 5. Global Lancets Sales by Type (2019-2024) & (K Units)
Table 6. Global Lancets Sales Market Share by Type (2019-2024)
Table 7. Global Lancets Revenue by Type (2019-2024) & ($ million)
Table 8. Global Lancets Revenue Market Share by Type (2019-2024)
Table 9. Global Lancets Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Lancets Sales by Application (2019-2024) & (K Units)
Table 11. Global Lancets Sales Market Share by Application (2019-2024)
Table 12. Global Lancets Revenue by Application (2019-2024)
Table 13. Global Lancets Revenue Market Share by Application (2019-2024)
Table 14. Global Lancets Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Lancets Sales by Company (2019-2024) & (K Units)
Table 16. Global Lancets Sales Market Share by Company (2019-2024)
Table 17. Global Lancets Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Lancets Revenue Market Share by Company (2019-2024)
Table 19. Global Lancets Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Lancets Producing Area Distribution and Sales Area
Table 21. Players Lancets Products Offered
Table 22. Lancets Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lancets Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Lancets Sales Market Share Geographic Region (2019-2024)
Table 27. Global Lancets Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Lancets Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Lancets Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Lancets Sales Market Share by Country/Region (2019-2024)
Table 31. Global Lancets Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Lancets Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Lancets Sales by Country (2019-2024) & (K Units)
Table 34. Americas Lancets Sales Market Share by Country (2019-2024)
Table 35. Americas Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Lancets Revenue Market Share by Country (2019-2024)
Table 37. Americas Lancets Sales by Type (2019-2024) & (K Units)
Table 38. Americas Lancets Sales by Application (2019-2024) & (K Units)
Table 39. APAC Lancets Sales by Region (2019-2024) & (K Units)
Table 40. APAC Lancets Sales Market Share by Region (2019-2024)
Table 41. APAC Lancets Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Lancets Revenue Market Share by Region (2019-2024)
Table 43. APAC Lancets Sales by Type (2019-2024) & (K Units)
Table 44. APAC Lancets Sales by Application (2019-2024) & (K Units)
Table 45. Europe Lancets Sales by Country (2019-2024) & (K Units)
Table 46. Europe Lancets Sales Market Share by Country (2019-2024)
Table 47. Europe Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Lancets Revenue Market Share by Country (2019-2024)
Table 49. Europe Lancets Sales by Type (2019-2024) & (K Units)
Table 50. Europe Lancets Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Lancets Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Lancets Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Lancets Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Lancets Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Lancets Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Lancets Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Lancets
Table 58. Key Market Challenges & Risks of Lancets
Table 59. Key Industry Trends of Lancets
Table 60. Lancets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lancets Distributors List
Table 63. Lancets Customer List
Table 64. Global Lancets Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Lancets Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Lancets Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Lancets Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Lancets Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Lancets Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Lancets Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Lancets Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Lancets Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Lancets Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Roche Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Lancets Product Portfolios and Specifications
Table 80. Roche Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Lifescan Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 84. Lifescan Lancets Product Portfolios and Specifications
Table 85. Lifescan Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Lifescan Main Business
Table 87. Lifescan Latest Developments
Table 88. BD Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Lancets Product Portfolios and Specifications
Table 90. BD Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Ascensia Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 94. Ascensia Lancets Product Portfolios and Specifications
Table 95. Ascensia Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Ascensia Main Business
Table 97. Ascensia Latest Developments
Table 98. Abbott Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Lancets Product Portfolios and Specifications
Table 100. Abbott Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. B. Braun Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 104. B. Braun Lancets Product Portfolios and Specifications
Table 105. B. Braun Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. B. Braun Main Business
Table 107. B. Braun Latest Developments
Table 108. ARKRAY Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 109. ARKRAY Lancets Product Portfolios and Specifications
Table 110. ARKRAY Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. ARKRAY Main Business
Table 112. ARKRAY Latest Developments
Table 113. Terumo Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 114. Terumo Lancets Product Portfolios and Specifications
Table 115. Terumo Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Terumo Main Business
Table 117. Terumo Latest Developments
Table 118. I-SENS Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 119. I-SENS Lancets Product Portfolios and Specifications
Table 120. I-SENS Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. I-SENS Main Business
Table 122. I-SENS Latest Developments
Table 123. Nipro Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Lancets Product Portfolios and Specifications
Table 125. Nipro Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Nipro Main Business
Table 127. Nipro Latest Developments
Table 128. Omron Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 129. Omron Lancets Product Portfolios and Specifications
Table 130. Omron Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Omron Main Business
Table 132. Omron Latest Developments
Table 133. AgaMatrix Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 134. AgaMatrix Lancets Product Portfolios and Specifications
Table 135. AgaMatrix Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. AgaMatrix Main Business
Table 137. AgaMatrix Latest Developments
Table 138. Smiths Medical Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 139. Smiths Medical Lancets Product Portfolios and Specifications
Table 140. Smiths Medical Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Smiths Medical Main Business
Table 142. Smiths Medical Latest Developments
Table 143. Sarstedt Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 144. Sarstedt Lancets Product Portfolios and Specifications
Table 145. Sarstedt Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Sarstedt Main Business
Table 147. Sarstedt Latest Developments
Table 148. Sinocare Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 149. Sinocare Lancets Product Portfolios and Specifications
Table 150. Sinocare Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Sinocare Main Business
Table 152. Sinocare Latest Developments
Table 153. Yicheng Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 154. Yicheng Lancets Product Portfolios and Specifications
Table 155. Yicheng Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Yicheng Main Business
Table 157. Yicheng Latest Developments
Table 158. Yuwell Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuwell Lancets Product Portfolios and Specifications
Table 160. Yuwell Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. Yuwell Main Business
Table 162. Yuwell Latest Developments
Table 163. Greiner Bio One Basic Information, Lancets Manufacturing Base, Sales Area and Its Competitors
Table 164. Greiner Bio One Lancets Product Portfolios and Specifications
Table 165. Greiner Bio One Lancets Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 166. Greiner Bio One Main Business
Table 167. Greiner Bio One Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lancets
Figure 2. Lancets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lancets Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Lancets Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Lancets Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Safety Lancets
Figure 10. Product Picture of Ordinary Lancets
Figure 11. Global Lancets Sales Market Share by Type in 2023
Figure 12. Global Lancets Revenue Market Share by Type (2019-2024)
Figure 13. Lancets Consumed in Cholesterol Tests
Figure 14. Global Lancets Market: Cholesterol Tests (2019-2024) & (K Units)
Figure 15. Lancets Consumed in Glucose Tests
Figure 16. Global Lancets Market: Glucose Tests (2019-2024) & (K Units)
Figure 17. Lancets Consumed in Others
Figure 18. Global Lancets Market: Others (2019-2024) & (K Units)
Figure 19. Global Lancets Sales Market Share by Application (2023)
Figure 20. Global Lancets Revenue Market Share by Application in 2023
Figure 21. Lancets Sales Market by Company in 2023 (K Units)
Figure 22. Global Lancets Sales Market Share by Company in 2023
Figure 23. Lancets Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Lancets Revenue Market Share by Company in 2023
Figure 25. Global Lancets Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Lancets Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Lancets Sales 2019-2024 (K Units)
Figure 28. Americas Lancets Revenue 2019-2024 ($ Millions)
Figure 29. APAC Lancets Sales 2019-2024 (K Units)
Figure 30. APAC Lancets Revenue 2019-2024 ($ Millions)
Figure 31. Europe Lancets Sales 2019-2024 (K Units)
Figure 32. Europe Lancets Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Lancets Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Lancets Revenue 2019-2024 ($ Millions)
Figure 35. Americas Lancets Sales Market Share by Country in 2023
Figure 36. Americas Lancets Revenue Market Share by Country in 2023
Figure 37. Americas Lancets Sales Market Share by Type (2019-2024)
Figure 38. Americas Lancets Sales Market Share by Application (2019-2024)
Figure 39. United States Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Lancets Sales Market Share by Region in 2023
Figure 44. APAC Lancets Revenue Market Share by Regions in 2023
Figure 45. APAC Lancets Sales Market Share by Type (2019-2024)
Figure 46. APAC Lancets Sales Market Share by Application (2019-2024)
Figure 47. China Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Lancets Sales Market Share by Country in 2023
Figure 55. Europe Lancets Revenue Market Share by Country in 2023
Figure 56. Europe Lancets Sales Market Share by Type (2019-2024)
Figure 57. Europe Lancets Sales Market Share by Application (2019-2024)
Figure 58. Germany Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Lancets Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Lancets Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Lancets Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Lancets Sales Market Share by Application (2019-2024)
Figure 67. Egypt Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lancets in 2023
Figure 73. Manufacturing Process Analysis of Lancets
Figure 74. Industry Chain Structure of Lancets
Figure 75. Channels of Distribution
Figure 76. Global Lancets Sales Market Forecast by Region (2025-2030)
Figure 77. Global Lancets Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Lancets Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Lancets Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Lancets Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Lancets Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Lancets
Figure 2. Lancets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lancets Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Lancets Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Lancets Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Safety Lancets
Figure 10. Product Picture of Ordinary Lancets
Figure 11. Global Lancets Sales Market Share by Type in 2023
Figure 12. Global Lancets Revenue Market Share by Type (2019-2024)
Figure 13. Lancets Consumed in Cholesterol Tests
Figure 14. Global Lancets Market: Cholesterol Tests (2019-2024) & (K Units)
Figure 15. Lancets Consumed in Glucose Tests
Figure 16. Global Lancets Market: Glucose Tests (2019-2024) & (K Units)
Figure 17. Lancets Consumed in Others
Figure 18. Global Lancets Market: Others (2019-2024) & (K Units)
Figure 19. Global Lancets Sales Market Share by Application (2023)
Figure 20. Global Lancets Revenue Market Share by Application in 2023
Figure 21. Lancets Sales Market by Company in 2023 (K Units)
Figure 22. Global Lancets Sales Market Share by Company in 2023
Figure 23. Lancets Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Lancets Revenue Market Share by Company in 2023
Figure 25. Global Lancets Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Lancets Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Lancets Sales 2019-2024 (K Units)
Figure 28. Americas Lancets Revenue 2019-2024 ($ Millions)
Figure 29. APAC Lancets Sales 2019-2024 (K Units)
Figure 30. APAC Lancets Revenue 2019-2024 ($ Millions)
Figure 31. Europe Lancets Sales 2019-2024 (K Units)
Figure 32. Europe Lancets Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Lancets Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Lancets Revenue 2019-2024 ($ Millions)
Figure 35. Americas Lancets Sales Market Share by Country in 2023
Figure 36. Americas Lancets Revenue Market Share by Country in 2023
Figure 37. Americas Lancets Sales Market Share by Type (2019-2024)
Figure 38. Americas Lancets Sales Market Share by Application (2019-2024)
Figure 39. United States Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Lancets Sales Market Share by Region in 2023
Figure 44. APAC Lancets Revenue Market Share by Regions in 2023
Figure 45. APAC Lancets Sales Market Share by Type (2019-2024)
Figure 46. APAC Lancets Sales Market Share by Application (2019-2024)
Figure 47. China Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Lancets Sales Market Share by Country in 2023
Figure 55. Europe Lancets Revenue Market Share by Country in 2023
Figure 56. Europe Lancets Sales Market Share by Type (2019-2024)
Figure 57. Europe Lancets Sales Market Share by Application (2019-2024)
Figure 58. Germany Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Lancets Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Lancets Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Lancets Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Lancets Sales Market Share by Application (2019-2024)
Figure 67. Egypt Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Lancets Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lancets in 2023
Figure 73. Manufacturing Process Analysis of Lancets
Figure 74. Industry Chain Structure of Lancets
Figure 75. Channels of Distribution
Figure 76. Global Lancets Sales Market Forecast by Region (2025-2030)
Figure 77. Global Lancets Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Lancets Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Lancets Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Lancets Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Lancets Revenue Market Share Forecast by Application (2025-2030)
